Literature DB >> 6251067

Specificity of promoter site utilization in vitro by bacterial RNA polymerases on Bacillus phage phi 29 DNA. Transcription mapping with exonuclease III.

B L Davison, C L Murray, J C Rabinowitz.   

Abstract

Bacillus subtilis RNA polymerase holoenzyme transcribes phi 29 DNA in vitro producing five major RNA species defined by characteristic electrophoretic mobilities. In addition to these products, Escherichia coli RNA polymerase transcribes phi 29 DNA to yield three RNA species not detected when transcribing with the B. subtilis enzyme under the same optimal reaction conditions for RNA synthesis. Transcriptional analysis of purified restriction fragments and exonuclease III-digested DNA established locations of six promoter and three termination sites defining the eight transcripts. The transcription map shows that E. coli RNA polymerase initiates transcription at three sites not efficiently utilized by the B. subtilis enzyme. However, initiation by the B. subtilis polymerase from at least two of these sites could be detected at E:DNA ratios greater than 10 in the absence of competing promoters. These results indicate that differences between the two polymerases in promoter utilization are not explained by specificity of promoter binding, but represent differences in responding to promoter strength. Transcription of phi 29 DNA and T7 DNA by E. coli core polymerase with either B. subtilis or E. coli sigma subunits results in formation of transcripts identical with those produced by E. coli holoenzyme, suggesting that core polymerase contains elements important in determining relative promoter strength. The efficiency of rifampicin-resistant complex formation on phi 29 and T7 promoters is also dependent upon the source of core polymerase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251067

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Properties of Bacillus subtilis sigma A factors with region 1.1 and the conserved Arg-103 at the N terminus of region 1.2 deleted.

Authors:  Hsin-Hsien Hsu; Wei-Cheng Huang; Jia-Perng Chen; Liang-Yin Huang; Chai-Fong Wu; Ban-Yang Chang
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

2.  Restoration of motility to an Escherichia coli fliA flagellar mutant by a Bacillus subtilis sigma factor.

Authors:  Y F Chen; J D Helmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  In vivo transcription of bacteriophage phi 29 DNA: transcription termination.

Authors:  I Barthelemy; M Salas; R P Mellado
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Nucleotide sequence of phage phi 29 gene 7: structure of intergenic spacer between the major early and late genes.

Authors:  C A Innis; K J Garvey; J Ito
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

5.  Purification in an active form of the phage phi 29 protein p4 that controls the viral late transcription.

Authors:  I Barthelemy; J M Lázaro; E Méndez; R P Mellado; M Salas
Journal:  Nucleic Acids Res       Date:  1987-10-12       Impact factor: 16.971

6.  Mapping the genes in the terminal redundancy of bacteriophage SPO1 with restriction endonucleases.

Authors:  M E Perkus; D A Shub
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

7.  Escherichia coli and Pseudomonas putida RNA polymerases display identical contacts with promoters.

Authors:  A I Gragerov; A A Chenchik; V A Aivasashvilli; R Sh Beabealashvilli; V G Nikiforov
Journal:  Mol Gen Genet       Date:  1984

8.  Nucleotide sequences at the termini of phi 29 DNA.

Authors:  H Yoshikawa; T Friedmann; J Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

Review 9.  The sigma factors of Bacillus subtilis.

Authors:  W G Haldenwang
Journal:  Microbiol Rev       Date:  1995-03

10.  In vitro transcription of the Bacillus subtilis phage phi 29 DNA by Bacillus subtilis and Escherichia coli RNA polymerases.

Authors:  J M Sogo; M Lozano; M Salas
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.